Skip to main content
Erschienen in: Clinical Neuroradiology 4/2023

28.06.2023 | Original Article

Treatment of Intracranial Vertebral Artery Dissecting Aneurysms Using Pipeline Embolization Devices

A Multicenter Cohort Study

verfasst von: Ying Zhang, Fujunhui Zhang, Mirzat Turhon, Jiliang Huang, Mengxing Li, Qichen Peng, Zhaoxu Zheng, Jian Liu, Yisen Zhang, Jianmin Liu, Hongqi Zhang, Tianxiao Li, Donglei Song, Yuanli Zhao, Maimaitili Aisha, Yunyan Wang, Wenfeng Feng, Yang Wang, Jieqing Wan, Guohua Mao, Huaizhang Shi, Sheng Guan

Erschienen in: Clinical Neuroradiology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Intracranial vertebral artery dissecting aneurysm (IVADA) is a rare type of aneurysm with high morbidity and mortality. Recently, the application of pipeline embolization devices (PEDs) has been extended to IVADAs. Here, we aim to investigate the safety and effectiveness of PEDs for IVADAs.

Method

We retrospectively reviewed the PLUS database to identify patients who had IVADAs and were treated with PEDs from 2014 to 2019 at 14 centers across China. Data including patient and aneurysm characteristics, procedure details, angiographic and clinical results, relationship with the ipsilateral posterior inferior cerebellar artery (PICA), and patency of the PICA following PED coverage were analyzed.

Results

In this study 52 consecutive patients with 52 IVADAs were included. The mean age was 52.33 years and 82.7% were male. With a median follow-up of 10.5 months, the complete occlusion rate was 93.8% (45/48) and no recurrence or in-stent stenosis was detected. The total postoperative complication rate and mortality were 11.5% and 1.9%, respectively. Complications occurred in 9.6% (5/52) of patients within 30 days after the operation, including ischemic stroke in 3 and hemorrhagic stroke in 2. Another patient suffered an ischemic stroke at follow-up, 78.8% (41/52) PICAs were covered by PEDs, 1 case (2.4%) had a functional disability due to PICA occlusion, while 39.0% (16/41) had reduced flow during follow-up but hardly caused any obvious neurological deficits. Patients with IVADA involving PICA had a trend towards more complications (66.7% vs. 51.1%; P = 1).

Conclusion

Treating IVADAs with PEDs may be a safe and effective option, with favorable clinical and angiographic outcomes; however, complications associated with this treatment should not be ignored.

Registration

http://​www.​clinicaltrials.​gov. Unique identifier: NCT03831672
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, Goeggel-Simonetti B, Engelter ST, Pezzini A, Bijlenga P, Southerland AM, Naggara O, Bejot Y, Cole JW, Ducros A, Giacalone G, Schilling S, Reiner P, Sarikaya H, Welleweerd JC, Kappelle LJ, de Borst GJ, Bonati LH, Jung S, Thijs V, Martin JJ, Brandt T, Grond-Ginsbach C, Kloss M, Mizutani T, Minematsu K, Meschia JF, Pereira VM, Bersano A, Touze E, Lyrer PA, Leys D, Chabriat H, Markus HS, Worrall BB, Chabrier S, Baumgartner R, Stapf C, Tatlisumak T, Arnold M, Bousser MG. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol. 2015;14(6):640–54. https://doi.org/10.1016/S1474-4422.CrossRefPubMed Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, Goeggel-Simonetti B, Engelter ST, Pezzini A, Bijlenga P, Southerland AM, Naggara O, Bejot Y, Cole JW, Ducros A, Giacalone G, Schilling S, Reiner P, Sarikaya H, Welleweerd JC, Kappelle LJ, de Borst GJ, Bonati LH, Jung S, Thijs V, Martin JJ, Brandt T, Grond-Ginsbach C, Kloss M, Mizutani T, Minematsu K, Meschia JF, Pereira VM, Bersano A, Touze E, Lyrer PA, Leys D, Chabriat H, Markus HS, Worrall BB, Chabrier S, Baumgartner R, Stapf C, Tatlisumak T, Arnold M, Bousser MG. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol. 2015;14(6):640–54. https://​doi.​org/​10.​1016/​S1474-4422.CrossRefPubMed
7.
Zurück zum Zitat Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran CJ, Woo HH, Lopes DK, Berez AL, Cher DJ, Siddiqui AH, Levy EI, Albuquerque FC, Fiorella DJ, Berentei Z, Marosfoi M, Cekirge SH, Nelson PK. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267(3):858–68. https://doi.org/10.1148/radiol.13120099.CrossRefPubMed Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, Moran CJ, Woo HH, Lopes DK, Berez AL, Cher DJ, Siddiqui AH, Levy EI, Albuquerque FC, Fiorella DJ, Berentei Z, Marosfoi M, Cekirge SH, Nelson PK. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267(3):858–68. https://​doi.​org/​10.​1148/​radiol.​13120099.CrossRefPubMed
8.
Zurück zum Zitat Luo B, Kang H, Zhang H, Li T, Liu J, Song D, Zhao Y, Guan S, Maimaitili A, Wang Y, Feng W, Wang Y, Wan J, Mao G, Shi H, Yang X. Pipeline Embolization device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion. Ther Adv Neurol Disord. 2020;13:1756286420967828. https://doi.org/10.1177/1756286420967828.CrossRefPubMedPubMedCentral Luo B, Kang H, Zhang H, Li T, Liu J, Song D, Zhao Y, Guan S, Maimaitili A, Wang Y, Feng W, Wang Y, Wan J, Mao G, Shi H, Yang X. Pipeline Embolization device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion. Ther Adv Neurol Disord. 2020;13:1756286420967828. https://​doi.​org/​10.​1177/​1756286420967828​.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat de Barros MF, Castro RN, Lundquist J, Scrivano E, Ceratto R, Ferrario A, Lylyk P. The role of the pipeline embolization device for the treatment of dissecting intracranial aneurysms. Ajnr Am J Neuroradiol. 2011;32(11):2192–5. https://doi.org/10.3174/ajnr.A2671.CrossRef de Barros MF, Castro RN, Lundquist J, Scrivano E, Ceratto R, Ferrario A, Lylyk P. The role of the pipeline embolization device for the treatment of dissecting intracranial aneurysms. Ajnr Am J Neuroradiol. 2011;32(11):2192–5. https://​doi.​org/​10.​3174/​ajnr.​A2671.CrossRef
16.
Zurück zum Zitat Turhon M, Kang H, Li M, Liu J, Zhang Y, Zhang Y, Huang J, Luo B, Liu J, Zhang H, Li T, Song D, Zhao Y, Guan S, Aximujiang A, Maimaitili A, Wang Y, Feng W, Wang Y, Wan J, Mao G, Shi H, Zhang X, Gu Y, Yang X. Treatment of fusiform aneurysms with a pipeline embolization device: a multicenter cohort study. J Neurointerv Surg. 2023;15(4):315–20. https://doi.org/10.1136/neurintsurg-2021-018539.CrossRefPubMed Turhon M, Kang H, Li M, Liu J, Zhang Y, Zhang Y, Huang J, Luo B, Liu J, Zhang H, Li T, Song D, Zhao Y, Guan S, Aximujiang A, Maimaitili A, Wang Y, Feng W, Wang Y, Wan J, Mao G, Shi H, Zhang X, Gu Y, Yang X. Treatment of fusiform aneurysms with a pipeline embolization device: a multicenter cohort study. J Neurointerv Surg. 2023;15(4):315–20. https://​doi.​org/​10.​1136/​neurintsurg-2021-018539.CrossRefPubMed
17.
Zurück zum Zitat Gupta G, Eckstein DA, Narayan V, Jumah F, DePalma AA, Sozio SJ, Prendergast N, Schonfeld S, Keller I, Al-Mufti F, Nosko M, Nanda A, Roychowdhury S. Endovascular Management of Intracranial Vertebral Artery Dissection: Technical Nuances for the Preservation of Posterior Inferior Cerebellar Artery and Basilar Artery. Oper Neurosurg. 2020;19(3):241–8. https://doi.org/10.1093/ons/opaa174.CrossRef Gupta G, Eckstein DA, Narayan V, Jumah F, DePalma AA, Sozio SJ, Prendergast N, Schonfeld S, Keller I, Al-Mufti F, Nosko M, Nanda A, Roychowdhury S. Endovascular Management of Intracranial Vertebral Artery Dissection: Technical Nuances for the Preservation of Posterior Inferior Cerebellar Artery and Basilar Artery. Oper Neurosurg. 2020;19(3):241–8. https://​doi.​org/​10.​1093/​ons/​opaa174.CrossRef
23.
Zurück zum Zitat Matsukawa H, Shinoda M, Fujii M, Takahashi O, Uemura A, Niimi Y. Basilar extension and posterior inferior cerebellar artery involvement as risk factors for progression of the unruptured spontaneous intradural vertebral artery dissection. J Neurol Neurosurg Psychiatry. 2014;85(9):1049–54. https://doi.org/10.1136/jnnp-2013-306931.CrossRefPubMed Matsukawa H, Shinoda M, Fujii M, Takahashi O, Uemura A, Niimi Y. Basilar extension and posterior inferior cerebellar artery involvement as risk factors for progression of the unruptured spontaneous intradural vertebral artery dissection. J Neurol Neurosurg Psychiatry. 2014;85(9):1049–54. https://​doi.​org/​10.​1136/​jnnp-2013-306931.CrossRefPubMed
24.
Metadaten
Titel
Treatment of Intracranial Vertebral Artery Dissecting Aneurysms Using Pipeline Embolization Devices
A Multicenter Cohort Study
verfasst von
Ying Zhang
Fujunhui Zhang
Mirzat Turhon
Jiliang Huang
Mengxing Li
Qichen Peng
Zhaoxu Zheng
Jian Liu
Yisen Zhang
Jianmin Liu
Hongqi Zhang
Tianxiao Li
Donglei Song
Yuanli Zhao
Maimaitili Aisha
Yunyan Wang
Wenfeng Feng
Yang Wang
Jieqing Wan
Guohua Mao
Huaizhang Shi
Sheng Guan
Publikationsdatum
28.06.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 4/2023
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-023-01318-7

Weitere Artikel der Ausgabe 4/2023

Clinical Neuroradiology 4/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.